Thyroid cancer is the most prevalent endocrine cancer worldwide. Angiogenesis, the
formation of new blood vessels, plays a pivotal role in the development and progression of …

Simple Summary Angiogenesis is an essential event for the progression of solid tumors and
is promoted by angiogenic cytokines released in the tumor microenvironment by neoplastic …

Context Angiogenesis has been recognized as an important process contributing to the
pathophysiology of many benign and malignant diseases. It is not surprising, therefore, that …

Our understanding of the molecular pathophysiology of differentiated thyroid cancer (DTC)
has developed considerably over the last 10 years. Aberrant signaling through B-Raf and …

Background Thyroid cancer, as with other types of cancer, is dependent on angiogenesis for
its continued growth and development. Interestingly, estrogen has been shown to contribute …

Angiogenesis is a physiological process involving the growth of new vessels from pre-
existing vasculature. Vascular endothelial growth factor (VEGF) is an important regulator of …

Experimental evidence has shown, both in vitro and in animal models, that neoplastic
growth and subsequent metastasis formation depend on the tumor's ability to induce an …

The role of angiogenesis and lymphangiogenesis in thyroid cancer pathogenesis has not
been elucidated. Patterns for tumour behaviour and metastasic spread vary according to …

Purpose: Thyroid-stimulating hormone (TSH) suppression is widely used to treat well-
differentiated thyroid cancer, whereas its role in poorly differentiated thyroid cancer (PDTC) …

Vascular endothelial growth factor (VEGF) promotes growth of blood or lymphatic vessels.
The aim of the current study is to identify relationships between VEGF-A and VEGF-C, and …